You are here

  • Home
  • Archive
  • Volume 83, Issue 11
  • Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al
Free

Authors

  • Antonis Fanouriakis 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece PubMed articlesGoogle scholar articles
  • George Bertsias Rheumatology and Clinical Immunology, University of Crete,Medical School, Iraklio, Greece Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece PubMed articlesGoogle scholar articles
  • Dimitrios T Boumpas 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Antonis Fanouriakis; afanour{at}med.uoa.gr
View Full Text

Citation

Fanouriakis A, Bertsias G, Boumpas DT
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al
Annals of the Rheumatic Diseases 2024;83:e25.

Publication history

  • Received September 6, 2024
  • Accepted September 8, 2024
  • First published September 18, 2024.
Online issue publication 
October 21, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.